Discontinuation report ARZERRA

Last updated on 2019-03-12 History
Report ID 78219
Drug Identification Number 02381567
Brand name ARZERRA
Common or Proper name ARZERRA 1000MG VIALS 50ML X 1
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Active Ingredient(s) Ofatumumab
Strength(s) 1000MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 50ML X 1
ATC code L01XC
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2019-03-11
Actual discontinuation date 2019-03-11
Remaining supply date 2019-03-11
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2019-03-12 English Compare
v2 2019-03-11 French Compare
v1 2019-03-11 English Compare